---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-000899"
form_type: "8-K"
ticker: "CMPX"
cik: "0001738021"
company_name: "Compass Therapeutics, Inc."
filed_at: "2023-02-10T23:59:59+00:00"
generated_at: "2026-06-19T18:09:07.847609+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Compass Therapeutics appoints David Wurzer to Board and as Audit Committee Chairman

## Summary
- David Wurzer appointed as Class III director effective Feb 8, 2023.
- Wurzer named Chairman of Audit Committee; independent and audit committee financial expert.
- Compensation: $45,000 cash retainer plus $10,000 for Audit Chair; 50,000-share option award vesting over 4 years.
- Wurzer is CFO of Enko Chem, Inc.; no family relationships or reportable transactions.

## SEC filing metadata
- accession: 0001171843-23-000899
- form_type: 8-K
- ticker: CMPX
- cik: 0001738021
- company_name: Compass Therapeutics, Inc.
- filed_at: 2023-02-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1738021/000117184323000899/0001171843-23-000899-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1738021/000117184323000899/f8k_021023.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-000899
- JSON: https://secwatch.observer/filing/0001171843-23-000899.json
- Plain text: https://secwatch.observer/filing/0001171843-23-000899.txt

## Key facts
- Executive change
  David Wurzer was appointed as Director at Compass Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: On February 8, 2023, the Board of Directors (the “Board”) of Compass Therapeutics, Inc. (the “Company”) approved the appointment of a new director to its Board: David Wurzer, CPA, CFO of Enko Chem, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1738021/000117184323000899/0001171843-23-000899-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.